You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ampyra

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Boston (drug, behavioral, other)

Not yet recruiting
  • Multiple Sclerosis
  • Dalfampridine 10 MG [Ampyra]
  • +2 more
  • Boston, Massachusetts
    MGH Institute of Health Professions
Nov 13, 2023

Motor Neuron Disease, Upper Trial in Gainesville, Boston, New York (dalfampridine)

Active, not recruiting
  • Motor Neuron Disease, Upper
  • Gainesville, Florida
  • +2 more
Mar 29, 2022

Multiple Sclerosis Trial in Buffalo (dalfampridine, )

Completed
Has Results
  • Multiple Sclerosis
  • Buffalo, New York
    Buffalo General Hospital
Sep 29, 2020

Multiple Sclerosis, Optic Neuritis Trial in Saint Louis (Dalfampridine/Placebo, Placebo/Dalfampridine)

Completed
Has Results
  • Multiple Sclerosis
  • Optic Neuritis
  • Dalfampridine/Placebo
  • Placebo/Dalfampridine
  • Saint Louis, Missouri
    Washington University (John L. Trotter MS Center)
Jan 23, 2020

Nerve Injury Trial in Hershey (4-Aminopyridine, Placebo oral tablet)

Terminated
Has Results
  • Nerve Injury
  • Hershey, Pennsylvania
    MS Hershey Medical Center
Oct 12, 2022

Multiple Sclerosis Trial in Kirkland (dalfampridine ER, )

Completed
Has Results
  • Multiple Sclerosis
  • dalfampridine ER
  • placebo
  • Kirkland, Washington
    MS Center at Evergreen
Oct 3, 2018

Parkinson's Disease Trial in Miami (Ampyra first, then Placebo, first, then Ampyra)

Completed
Has Results
  • Parkinson's Disease
  • Ampyra first, then Placebo
  • placebo first, then Ampyra
  • Miami, Florida
    University of Miami
Dec 5, 2017

Multiple Sclerosis Trial in Denmark (Fampridine-SR)

Completed
  • Multiple Sclerosis
  • Esbjerg, Denmark
  • +3 more
Aug 22, 2018

Central and Peripheral Nervous System Changes as Markers of

Completed
  • Multiple Sclerosis
  • +7 more
    • Sønderborg, Jylland, Denmark
      Department of Neurology (Skleroseklinikken), Sygehus Sønderjylla
    Oct 13, 2021

    Transverse Myelitis, Neuromyelitis Optica, Idiopathic Transverse Myelitis Trial in Baltimore (Dalfampridine, Placebo)

    Completed
    Has Results
    • Transverse Myelitis
    • +3 more
    • Baltimore, Maryland
      Johns Hopkins University
    Mar 14, 2018

    Episodic Ataxia Type 2 Trial in Los Angeles, Tampa, Rochester (4-Aminopyridine, Placebo)

    Withdrawn
    • Episodic Ataxia Type 2
    • Los Angeles, California
    • +2 more
    Nov 12, 2020

    Spinal Cord Injury Trial in West Orange (Dalfampridine, Placebo)

    Completed
    • Spinal Cord Injury
    • West Orange, New Jersey
      Kessler Institute for Rehabilitation
    Nov 29, 2017

    to Document Drug Utilization of Fampyra When Used In Routine

    Completed
    • Multiple Sclerosis
    • Ciudad Autonoma de Buanos Aires, Buenos Aires, Argentina
    • +167 more
    Jun 4, 2019

    Post-ischemic Stroke Trial in Canada, United States (dalfampridine-ER 7.5 mg, dalfampridine-ER 10 mg)

    Terminated
    Has Results
    • Post-ischemic Stroke
    • dalfampridine-ER 7.5 mg
    • dalfampridine-ER 10 mg
    • Gilbert, Arizona
    • +65 more
    Jan 17, 2019

    Post-Ischemic Stroke Trial in Canada, United States (Placebo, dalfampridine-ER 7.5mg, dalfampridine-ER 10mg)

    Completed
    Has Results
    • Post-Ischemic Stroke
    • Placebo
    • +2 more
    • Gilbert, Arizona
    • +73 more
    Jun 4, 2018

    Multiple Sclerosis, Pregnancy Trial in Paris (Fampridine)

    Terminated
    • Multiple Sclerosis
    • Pregnancy
    • Paris, France
      Hopital Pitie Salpetriere
    Oct 17, 2016

    Multiple Sclerosis, Remittent Progressive, Multiple Sclerosis, Primary Progressive, Relapsing-Remitting Multiple Sclerosis Trial

    Completed
    • Multiple Sclerosis, Remittent Progressive
    • +4 more
    • Placebo
    • BIIB041 (fampridine)
    • Bunkyo-ku, Japan
    • +18 more
    Mar 17, 2017

    Multiple Sclerosis Trial in Worldwide (BIIB041 (PR Fampridine), Placebo)

    Completed
    • Multiple Sclerosis
    • BIIB041 (PR Fampridine)
    • Placebo
    • Ath, Belgium
    • +22 more
    Jan 5, 2017

    Spinal Muscular Atrophy Trial in New York (4-aminopyridine, Placebo)

    Completed
    • Spinal Muscular Atrophy
    • New York, New York
      Columbia University Medical Center
    May 17, 2016

    Multiple Sclerosis Trial in Worldwide (Fampridine)

    Completed
    Has Results
    • Multiple Sclerosis
    • Concord, New South Wales, Australia
    • +58 more
    Feb 14, 2017

    Multiple Sclerosis Trial in Worldwide (fampridine, Placebo)

    Completed
    Has Results
    • Multiple Sclerosis
    • Cullman, Alabama
    • +86 more
    Feb 6, 2017

    Non Arteritic Ischemic Optic Neuropathy Trial in Philadelphia (dalfampridine, Placebo)

    Completed
    • Non Arteritic Ischemic Optic Neuropathy
    • Philadelphia, Pennsylvania
      Neuro-Ophthalmologic Associates, PC
    Jan 22, 2016

    Multiple Sclerosis Trial in Zurich (Prolonged-release Fampridine, Placebo)

    Unknown status
    • Multiple Sclerosis
    • Prolonged-release Fampridine
    • Placebo
    • Zurich, ZH, Switzerland
      University Hospital Zurich, Division of Neurology
    Dec 3, 2015

    Spinocerebellar Ataxias Type 1, Spinocerebellar Ataxias Type 2, Spinocerebellar Ataxias Type 3 Trial in Gainesville

    Completed
    Has Results
    • Spinocerebellar Ataxias Type 1
    • +3 more
    • Gainesville, Florida
      University of Florida
    Jan 8, 2015

    Multiple Sclerosis Trial in Tel-hashomer (Sustained-release oral dalfampridine, Placebo)

    Unknown status
    • Multiple Sclerosis
    • Sustained-release oral dalfampridine
    • Placebo
    • Tel-hashomer, Ramat-gan, Israel
      Multiple Sclerosis Center
    Oct 5, 2014